Related by context. Frequent words. (Click for all words.) 65 Medical Oncology ESMO 62 Hematology Annual Meeting 62 Clinical Oncology Annual Meeting 62 Annual Scientific Sessions 61 Transcatheter Cardiovascular Therapeutics TCT 60 Clinical Trial Results 59 EORTC NCI AACR Symposium 59 League Against Rheumatism 58 randomized Phase III 58 Digestive Disease Week DDW 57 Breast Cancer Symposium 57 EuroPCR 57 ASCO Annual Meeting 56 Clinical Microbiology 56 Clinical Oncology ASCO Annual 56 Chemotherapy ICAAC 55 Scientific Sessions 55 ARVO 55 axitinib 55 Liver EASL 55 placebo controlled clinical 55 Molecular Targets 55 Digestive Disease Week 55 AACR NCI EORTC 54 Phase 2a clinical 54 phase IIa 54 multicenter clinical 54 Chronic Lymphocytic Leukemia 54 substudy 54 Lung Transplantation 54 ESMO 54 Postmenopausal Women 54 randomized controlled clinical 53 ICAAC 53 Neurology AAN 53 Scientific Session 52 EORTC 52 Solid Tumors 52 Phase 1b trial 52 SPIRIT III 52 Hematology ASH 52 J Am Coll 52 HER2 positive metastatic breast 51 Bortezomib 51 CTI Nasdaq 51 J Clin Oncol 51 Meta Analysis 51 Therapeutic Radiology 51 Antimicrobial Agents 51 Respiratory Society 51 prospective observational 51 Pharmacokinetic 51 AACR Annual Meeting 51 Phase 2a trial 51 American Roentgen Ray 51 Controlled Release 51 subgroup analyzes 51 Interscience Conference 51 RGB # 51 Liver Diseases AASLD 51 relapsed refractory multiple myeloma 51 National Surgical Adjuvant 50 ALN VSP 50 phase IIb 50 relapsed multiple myeloma 50 Murdo Maguire 50 Heart Failure Society 50 LymphoStat B 50 CAPRISA 50 Clinical Oncology ASCO 50 Retroviruses 50 metastatic renal cell carcinoma 50 Opportunistic Infections 50 Perifosine 50 INGN 50 CoFactor 50 Cardiology ESC 50 Oral Presentation 50 Heart Failure Patients 50 Annual BIO 50 Poster Presentation 50 Cardiology ACC 50 Reolysin 50 Cardiol 50 EASL 49 Monoclonal Antibodies 49 phase 2a 49 OXi# 49 decitabine 49 resistant ovarian cancer 49 Thoracic Oncology 49 aflibercept 49 HGS ETR1 49 mCRC 49 San Antonio Breast Cancer 49 Molecular Cancer 49 Phase Ib 49 Cell Lung Cancer 48 #:#-# [031] 48 Everolimus 48 Drug Eluting Stents